Newsroom

New therapies, like SGLT2 inhibitors and GLP-1 receptor agonists, offer hope by slowing kidney disease progression and improving outcomes.

Tetracycline antibiotics can be used for up to three weeks during breast-feeding, as low milk excretion and minimal reported adverse effects have extended the recommended use.

At least one actionable pharmacogenetic mutation is present in 97-99% of population (1,2) and more than half of them had three or more mutations (2).

Ashwagandha may cause cholestatic hepatitis and elevated liver enzymes.

Drug therapies don’t always work as expected. For some patients, the drugs have no effect, while others may experience severe adverse reactions.

Markus Jansén, M.Sc. (Tech.), began his new role in April, motivated by the meaningful impact of his work.

Finland is exceptionally advanced in utilising user-friendly, high-quality drug information in everyday clinical work. This is largely due to…